Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
18 October 2019 | Story Ruan Bruwer | Photo Getty Images
Jaco Peyper
Jaco Peyper, former Kovsie, will handle a quarter-final match at the Rugby World Cup. It will also be his 50th test match.
With the appointment of Jaco Peyper as referee there will be Kovsie alumni among the referees, players and coaches in the quarter-finals of the 2019 Rugby World Cup in Japan on 20 October.

Lappies Labuschagné will start on the flank for Japan in their clash against the Springboks on Sunday. Labuschagné, a former Shimla captain, is second on the list for tackles made in the tournament thus far.
In the Springbok camp there are former University of the Free State (UFS) students in Rassie Erasmus (head coach) and Jacques Nienaber (defence coach).

UFS alumnus Jaco Peyper has been entrusted with the whistle in Sunday’s other quarter-final between Wales and France. It will be a memorable match for Peyper as it will be his 50th test appearance as the 31st man on the field – making him only the third South African to achieve this feat.

Peyper, who is the only South African among the 12 referees at the tournament, made his World Cup debut in 2015 when he officiated the opening match. In total he has handled six World Cup encounters. 

His illustrious career has seen him become only the fourth referee in history to officiate in 100 Super Rugby matches earlier in the year, in which he also handled the final (his fourth Super Rugby final). Peyper scooped the SA Referee of the Year award in 2018 for a third time, a year in which he took charge of his fourth Currie Cup Final.

“The fact that he is only the third South African referee to take charge of 50 tests indicates what a special achievement this is. It takes years of hard work and dedication to reach this level as a referee, and to maintain this standard year-in and year-out is even more challenging as it requires one to produce effective performances consistently,” said Jurie Roux, the CEO of SA Rugby.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept